Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Immunologic Factors"" wg kryterium: Temat


Tytuł:
The C5aR1 complement receptor: A novel immunomodulator of insulin action in skeletal muscle.
Autorzy:
Shah DS; Division of Cell Signalling and Immunology, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.
McNeilly AD; Division of Systems Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
McCrimmon RJ; Division of Systems Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
Hundal HS; Division of Cell Signalling and Immunology, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK. Electronic address: .
Pokaż więcej
Źródło:
Cellular signalling [Cell Signal] 2024 Jan; Vol. 113, pp. 110944. Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:
Journal Article
MeSH Terms:
Immunologic Factors*/metabolism
Insulin*/physiology
Receptor, Anaphylatoxin C5a*/metabolism
Humans ; Muscle, Skeletal/metabolism ; Signal Transduction
Czasopismo naukowe
Tytuł:
Software for evaluation of immune cell activation (Application note).
Autorzy:
Goranov V; BioDevice Systems SME, Praha 10, Vršovice, Bulharská 996/20, Czech Republic. Electronic address: .
Makhaniok A; BioDevice Systems SME, Praha 10, Vršovice, Bulharská 996/20, Czech Republic.
Pokaż więcej
Źródło:
Bio Systems [Biosystems] 2024 Jan; Vol. 235, pp. 105092. Date of Electronic Publication: 2023 Dec 02.
Typ publikacji:
Journal Article
MeSH Terms:
Macrophages*/metabolism
Immunologic Factors*/metabolism
Humans ; Software
Czasopismo naukowe
Tytuł:
Editorial: Regulation of the phenotype and function of human macrophages and dendritic cells by exogenous immunomodulators.
Autorzy:
Bazzi S; Department of Biomedical Sciences, Faculty of Medicine and Medical Sciences, University of Balamand, Al Koura, Lebanon.
Bahr GM; Department of Biomedical Sciences, Faculty of Medicine and Medical Sciences, University of Balamand, Al Koura, Lebanon.
Lampiasi N; Istituto per la Ricerca e l'Innovazione Biomedica, Consiglio Nazionale delle Ricerche, Palermo, Italy.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Dec 19; Vol. 14, pp. 1353765. Date of Electronic Publication: 2023 Dec 19 (Print Publication: 2023).
Typ publikacji:
Editorial
MeSH Terms:
Immunologic Factors*/pharmacology
Adjuvants, Immunologic*
Humans ; Phenotype ; Dendritic Cells
Opinia redakcyjna
Tytuł:
Macrophage Polarization: Learning to Manage It 2.0.
Autorzy:
Lampiasi N; Istituto per la Ricerca e l'Innovazione Biomedica IRIB, Consiglio Nazionale delle Ricerche, Via Ugo La Malfa 153, 90146 Palermo, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 12; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Editorial
MeSH Terms:
Macrophages*
Immunologic Factors*
Macrophage Activation ; Adjuvants, Immunologic
Opinia redakcyjna
Tytuł:
A Case of a Serum Sickness-Like Reaction After Postexposure Rabies Prophylaxis.
Autorzy:
Galeano KJ; Department of Emergency and Hospital Medicine, Lehigh Valley Health Network, USF Morsani College of Medicine, Allentown, Pennsylvania.
Tay VQ; Department of Emergency and Hospital Medicine, Lehigh Valley Health Network, USF Morsani College of Medicine, Allentown, Pennsylvania.
Amaducci AM; Department of Emergency and Hospital Medicine, Lehigh Valley Health Network, USF Morsani College of Medicine, Allentown, Pennsylvania.
Pokaż więcej
Źródło:
The Journal of emergency medicine [J Emerg Med] 2023 Dec; Vol. 65 (6), pp. e531-e533. Date of Electronic Publication: 2023 Aug 15.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Immunologic Factors*/adverse effects
Rabies*/prevention & control
Rabies Vaccines*/adverse effects
Serum Sickness*/etiology
Adult ; Humans ; Male
Czasopismo naukowe
Tytuł:
Immunomodulatory mechanisms of an acidic polysaccharide from the fermented burdock residue by Rhizopus nigricans in RAW264.7 cells and cyclophosphamide-induced immunosuppressive mice.
Autorzy:
Xu X; School of Life Science and National Glycoengineering Research Center, Shandong University, Qingdao 266237, PR China.
Shao T; Anhui Provincial Engineering Research Center for Polysaccharide Drugs, Anhui Province Key Laboratory of Active Biological Macromolecules, Drug Research &Development Center, School of Pharmacy, Wannan Medical College, Wuhu 241002, PR China.
Meng Y; School of Life Science and National Glycoengineering Research Center, Shandong University, Qingdao 266237, PR China.
Liu C; Anhui Provincial Engineering Research Center for Polysaccharide Drugs, Anhui Province Key Laboratory of Active Biological Macromolecules, Drug Research &Development Center, School of Pharmacy, Wannan Medical College, Wuhu 241002, PR China. Electronic address: .
Zhang P; School of Life Science and National Glycoengineering Research Center, Shandong University, Qingdao 266237, PR China. Electronic address: .
Chen K; School of Life Science and National Glycoengineering Research Center, Shandong University, Qingdao 266237, PR China. Electronic address: .
Pokaż więcej
Źródło:
International journal of biological macromolecules [Int J Biol Macromol] 2023 Dec 01; Vol. 252, pp. 126462. Date of Electronic Publication: 2023 Aug 22.
Typ publikacji:
Journal Article
MeSH Terms:
Immunologic Factors*/pharmacology
Arctium*
Animals ; Mice ; Toll-Like Receptor 4/metabolism ; Cytokines/metabolism ; RAW 264.7 Cells ; NF-kappa B/metabolism ; Immunosuppressive Agents/pharmacology ; Mitogen-Activated Protein Kinases/metabolism ; Cyclophosphamide/adverse effects ; Immunoglobulins ; Polysaccharides/pharmacology ; Polysaccharides/chemistry
SCR Organism:
Rhizopus stolonifer
Czasopismo naukowe
Tytuł:
Author's Reply: "Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?"
Autorzy:
Sousa P; Department of Gastroenterology, Viseu-Tondela Hospital Centre, Viseu, Portugal.
Magro F; Center for Health Technology and Services Research (CINTESIS), Porto, Portugal; Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal; , Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal; Department of Gastroenterology, São João Hospital University Centre, Porto, Portugal; Unidade de Farmacologia Clínica, São João Hospital University Centre, Porto, Portugal. Electronic address: .
Pokaż więcej
Źródło:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2024 Mar; Vol. 56 (3), pp. 532-533. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Letter
MeSH Terms:
Immunologic Factors*/therapeutic use
Crohn Disease*/drug therapy
Humans ; Infliximab/therapeutic use ; Combined Modality Therapy ; Drug Therapy, Combination
Opinia redakcyjna
Tytuł:
Rituximab as a sole steroid-sparing agent in generalized myasthenia gravis: Long-term outcomes.
Autorzy:
Kefalopoulou ZM; Department of Neurology, University Hospital of Patras, 26504, Patras, Rio, Greece. .; Neuromuscular Centre, University Hospital of Patras, 26504, Patras, Rio, Greece. .
Veltsista D; Department of Neurology, University Hospital of Patras, 26504, Patras, Rio, Greece.; Neuromuscular Centre, University Hospital of Patras, 26504, Patras, Rio, Greece.
Germeni A; Department of Neurology, University Hospital of Patras, 26504, Patras, Rio, Greece.
Lykouras D; Department of Respiratory Medicine, University Hospital of Patras, 26504, Patras, Rio, Greece.
Tsiamaki E; Department of Neurology, University Hospital of Patras, 26504, Patras, Rio, Greece.
Chroni E; Department of Neurology, University Hospital of Patras, 26504, Patras, Rio, Greece.; Neuromuscular Centre, University Hospital of Patras, 26504, Patras, Rio, Greece.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Mar; Vol. 45 (3), pp. 1233-1242. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article
MeSH Terms:
Immunologic Factors*/therapeutic use
Myasthenia Gravis*/drug therapy
Adult ; Humans ; Rituximab/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Steroids/therapeutic use ; Recurrence ; Autoantibodies
Czasopismo naukowe
Tytuł:
Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?
Autorzy:
Yuksel I; Department of Gastroenterology, Ankara Bilkent City Hospital, Ankara, Turkey; Department of Gastroenterology, Ankara Yildirim Beyazit University School of Medicine, Ankara, Turkey. Electronic address: .
Cagir Y; Department of Gastroenterology, Ankara Bilkent City Hospital, Ankara, Turkey.
Atay A; Department of Gastroenterology, Ankara Bilkent City Hospital, Ankara, Turkey.
Pokaż więcej
Źródło:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2024 Mar; Vol. 56 (3), pp. 530-531. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:
Letter
MeSH Terms:
Immunologic Factors*
Antibodies, Monoclonal*/therapeutic use
Humans ; Infliximab/therapeutic use ; Combined Modality Therapy ; Drug Therapy, Combination ; Treatment Outcome ; Gastrointestinal Agents/therapeutic use
Opinia redakcyjna
Tytuł:
Real world study of ocrelizumab in multiple sclerosis: Kuwait experience.
Autorzy:
Alroughani R; Division of Neurology, Amiri Hospital, Arabian Gulf Street, Sharq 13041, Kuwait; MS Clinic, Ibn Sina Hospital, P.O. Box 25427, Safat 13115, Kuwait.
AlMojel M; Department of Medicine, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait.
Al-Hashel J; Department of Medicine, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait; Department of Neurology, Ibn Sina Hospital, P.O. Box 25427, Safat 13115, Kuwait.
Ahmed SF; Department of Medicine, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait; Department of Neurology and Psychiatry, Minia University, P.O. Box 61519, Minia 61111, Egypt. Electronic address: .
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2023 Nov; Vol. 79, pp. 104941. Date of Electronic Publication: 2023 Aug 18.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Immunologic Factors*/adverse effects
Multiple Sclerosis*/diagnostic imaging
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/chemically induced
Female ; Humans ; Male ; Kuwait ; Adult ; Middle Aged
Czasopismo naukowe
Tytuł:
An outlook on the target-based molecular mechanism of phytoconstituents as immunomodulators.
Autorzy:
Noor G; Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, India.
Badruddeen; Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, India.
Akhtar J; Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, India.
Singh B; Department of Pharmacognosy, S.D. College of Pharmacy and Vocational Studies, Muzaffarnagar, India.
Ahmad M; Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, India.
Khan MI; Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, India.
Pokaż więcej
Źródło:
Phytotherapy research : PTR [Phytother Res] 2023 Nov; Vol. 37 (11), pp. 5058-5079. Date of Electronic Publication: 2023 Aug 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunologic Factors*/pharmacology
Cytokines*
Adjuvants, Immunologic/pharmacology ; Immunity, Humoral ; Immune System
Czasopismo naukowe
Tytuł:
Interaction of S100A6 Protein with the Four-Helical Cytokines.
Autorzy:
Kazakov AS; Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Institute for Biological Instrumentation, Institutskaya str., 7, Pushchino, Moscow Region 142290, Russia.
Deryusheva EI; Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Institute for Biological Instrumentation, Institutskaya str., 7, Pushchino, Moscow Region 142290, Russia.
Rastrygina VA; Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Institute for Biological Instrumentation, Institutskaya str., 7, Pushchino, Moscow Region 142290, Russia.
Sokolov AS; Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Institute for Biological Instrumentation, Institutskaya str., 7, Pushchino, Moscow Region 142290, Russia.
Permyakova ME; Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Institute for Biological Instrumentation, Institutskaya str., 7, Pushchino, Moscow Region 142290, Russia.
Litus EA; Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Institute for Biological Instrumentation, Institutskaya str., 7, Pushchino, Moscow Region 142290, Russia.
Uversky VN; Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Institute for Biological Instrumentation, Institutskaya str., 7, Pushchino, Moscow Region 142290, Russia.; Department of Molecular, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.; USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
Permyakov EA; Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Institute for Biological Instrumentation, Institutskaya str., 7, Pushchino, Moscow Region 142290, Russia.
Permyakov SE; Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Institute for Biological Instrumentation, Institutskaya str., 7, Pushchino, Moscow Region 142290, Russia.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2023 Sep 04; Vol. 13 (9). Date of Electronic Publication: 2023 Sep 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunologic Factors*
S100 Proteins*
Humans ; Animals ; S100 Calcium Binding Protein A6 ; Molecular Docking Simulation ; Binding Sites ; Cell Cycle Proteins
Czasopismo naukowe
Tytuł:
The structure, characterization and immunomodulatory potential of exopolysaccharide produced by Planococcus rifietoensis AP-5 from deep-sea sediments of the Northwest Pacific.
Autorzy:
Hu X; Frontiers Science Center for Deep Ocean Multispheres and Earth System, Key Laboratory of Marine Chemistry Theory and Technology, Ministry of Education, Ocean University of China, Qingdao 266100, China; College of Chemistry & Chemical Engineering, Ocean University of China, Qingdao 266100, China.
Zhao S; Frontiers Science Center for Deep Ocean Multispheres and Earth System, Key Laboratory of Marine Chemistry Theory and Technology, Ministry of Education, Ocean University of China, Qingdao 266100, China; College of Chemistry & Chemical Engineering, Ocean University of China, Qingdao 266100, China.
Li F; Frontiers Science Center for Deep Ocean Multispheres and Earth System, Key Laboratory of Marine Chemistry Theory and Technology, Ministry of Education, Ocean University of China, Qingdao 266100, China; College of Chemistry & Chemical Engineering, Ocean University of China, Qingdao 266100, China.
Zhang X; Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266100, China.
Pan Y; Frontiers Science Center for Deep Ocean Multispheres and Earth System, Key Laboratory of Marine Chemistry Theory and Technology, Ministry of Education, Ocean University of China, Qingdao 266100, China; College of Chemistry & Chemical Engineering, Ocean University of China, Qingdao 266100, China.
Lu J; Frontiers Science Center for Deep Ocean Multispheres and Earth System, Key Laboratory of Marine Chemistry Theory and Technology, Ministry of Education, Ocean University of China, Qingdao 266100, China; College of Chemistry & Chemical Engineering, Ocean University of China, Qingdao 266100, China.
Li Y; Frontiers Science Center for Deep Ocean Multispheres and Earth System, Key Laboratory of Marine Chemistry Theory and Technology, Ministry of Education, Ocean University of China, Qingdao 266100, China; College of Chemistry & Chemical Engineering, Ocean University of China, Qingdao 266100, China.
Bao M; Frontiers Science Center for Deep Ocean Multispheres and Earth System, Key Laboratory of Marine Chemistry Theory and Technology, Ministry of Education, Ocean University of China, Qingdao 266100, China; College of Chemistry & Chemical Engineering, Ocean University of China, Qingdao 266100, China. Electronic address: .
Pokaż więcej
Źródło:
International journal of biological macromolecules [Int J Biol Macromol] 2023 Aug 01; Vol. 245, pp. 125452. Date of Electronic Publication: 2023 Jun 16.
Typ publikacji:
Journal Article
MeSH Terms:
Polysaccharides*/pharmacology
Polysaccharides*/chemistry
Immunologic Factors*/pharmacology
Immunologic Factors*/chemistry
Cytokines ; Molecular Weight
SCR Organism:
Planococcus rifietoensis
Czasopismo naukowe
Tytuł:
Plants and Plant-Derived Molecules as Natural Immunomodulators.
Autorzy:
Zebeaman M; Center of Excellence in Nanotechnology, P.O. Box 16417, Addis Ababa, Ethiopia.; Department of Industrial Chemistry, Addis Ababa Science and Technology University, College of Applied Science, P.O. Box 16417, Addis Ababa, Ethiopia.
Tadesse MG; Center of Excellence in Nanotechnology, P.O. Box 16417, Addis Ababa, Ethiopia.; Centre of Excellence in Biotechnology and Bioprocess, P.O. Box 16417, Addis Ababa, Ethiopia.
Bachheti RK; Center of Excellence in Nanotechnology, P.O. Box 16417, Addis Ababa, Ethiopia.; Department of Industrial Chemistry, Addis Ababa Science and Technology University, College of Applied Science, P.O. Box 16417, Addis Ababa, Ethiopia.; Centre of Excellence in Biotechnology and Bioprocess, P.O. Box 16417, Addis Ababa, Ethiopia.
Bachheti A; Department of Environment Science, Graphic Era University, Dehradun, 248002 Uttarakhand, India.
Gebeyhu R; Microbiology Department, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Chaubey KK; Division of Research and Innovation, Uttaranchal University, Arcadia Grant, P.O. Chandanwari, Premnagar, Dehradun, Uttarakhand 248007, India.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2023 Jun 05; Vol. 2023, pp. 7711297. Date of Electronic Publication: 2023 Jun 05 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunologic Factors*/pharmacology
Immunologic Factors*/therapeutic use
Asteraceae*
Adjuvants, Immunologic/pharmacology ; Adjuvants, Immunologic/therapeutic use ; Cytokines ; Immunosuppressive Agents ; Immunomodulating Agents
Czasopismo naukowe
Tytuł:
The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis.
Autorzy:
Kivitz A; Department of Rheumatology, Altoona Center for Clinical Research, Altoona, Pennsylvania, USA.
Wang L; Horizon Therapeutics plc, Rockville, Maryland, USA.
Alevizos I; Horizon Therapeutics plc, Rockville, Maryland, USA.
Gunsior M; Horizon Therapeutics plc, Rockville, Maryland, USA.
Falloon J; Horizon Therapeutics plc, Rockville, Maryland, USA.
Illei G; Horizon Therapeutics plc, Rockville, Maryland, USA.; IRD Biomedical Consulting, LLC, Rockville, Maryland, USA.
St Clair EW; Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA .
Pokaż więcej
Źródło:
RMD open [RMD Open] 2023 Aug; Vol. 9 (3).
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Arthritis, Rheumatoid*/drug therapy
Immunologic Factors*/adverse effects
Adult ; Humans ; Antirheumatic Agents ; Double-Blind Method ; Methotrexate ; Rheumatoid Factor
Czasopismo naukowe
Tytuł:
Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center.
Autorzy:
Gomes R; Centro Hospitalar Universitário do Porto, Centro Materno-Infantil do Norte, Serviço de Pediatria, Porto, Portugal.
Mosca S; Centro Hospitalar Universitário do Porto, Centro Materno-Infantil do Norte, Serviço de Pediatria, Porto, Portugal.
Bastos-Gomes M; Unidade Local de Saúde do Alto Minho, Serviço de Pediatria, EPE, Viana do Castelo, Portugal.
Correia-Costa L; Centro Hospitalar Universitário do Porto, Centro Materno-Infantil do Norte, Serviço de Pediatria, Unidade de Nefrologia Pediátrica, Porto, Portugal.
Rocha L; Centro Hospitalar Universitário do Porto, Centro Materno-Infantil do Norte, Serviço de Pediatria, Unidade de Nefrologia Pediátrica, Porto, Portugal.
Teixeira A; Centro Hospitalar Universitário do Porto, Centro Materno-Infantil do Norte, Serviço de Pediatria, Unidade de Nefrologia Pediátrica, Porto, Portugal.
Costa T; Centro Hospitalar Universitário do Porto, Centro Materno-Infantil do Norte, Serviço de Pediatria, Unidade de Nefrologia Pediátrica, Porto, Portugal.
Sameiro-Faria M; Centro Hospitalar Universitário do Porto, Centro Materno-Infantil do Norte, Serviço de Pediatria, Unidade de Nefrologia Pediátrica, Porto, Portugal.
Matos P; Centro Hospitalar Universitário do Porto, Centro Materno-Infantil do Norte, Serviço de Pediatria, Unidade de Nefrologia Pediátrica, Porto, Portugal.
Mota C; Centro Hospitalar Universitário do Porto, Centro Materno-Infantil do Norte, Serviço de Pediatria, Unidade de Nefrologia Pediátrica, Porto, Portugal.
Pokaż więcej
Źródło:
Jornal brasileiro de nefrologia [J Bras Nefrol] 2023 Jul-Sep; Vol. 45 (3), pp. 326-334.
Typ publikacji:
Journal Article
MeSH Terms:
Immunologic Factors*/therapeutic use
Nephrotic Syndrome*/drug therapy
Nephrotic Syndrome*/diagnosis
Male ; Child ; Humans ; Adolescent ; Child, Preschool ; Rituximab/adverse effects ; Retrospective Studies ; Portugal ; Treatment Outcome ; Immunosuppressive Agents/therapeutic use ; Steroids/therapeutic use ; Recurrence
SCR Disease Name:
Nephrosis, congenital
Czasopismo naukowe
Tytuł:
An electrospun macrodevice for durable encapsulation of human cells with consistent secretion of therapeutic antibodies.
Autorzy:
Imaichi-Kobayashi S; Department of Pharmaceutical Science, Takeda Pharmaceuticals, Cambridge, MA, USA.
Kassab R; BioSurfaces, LLC, Ashland, MA, USA.
Piersigilli A; Department of Drug Safety Research and Evaluation, Takeda Pharmaceuticals, Cambridge, MA, USA.
Robertson R; Quanta Imaging, LLC, Everett, MA, USA.
Leonard C; Department of Drug Safety Research and Evaluation, Takeda Pharmaceuticals, Cambridge, MA, USA.
Long N; BioSurfaces, LLC, Ashland, MA, USA.
Dean B; Iridium Bioscience, Walpole, MA, USA.
Phaneuf M; BioSurfaces, LLC, Ashland, MA, USA.
Ling V; Department of Pharmaceutical Science, Takeda Pharmaceuticals, Cambridge, MA, USA. Electronic address: .
Pokaż więcej
Źródło:
Biomaterials [Biomaterials] 2023 Jul; Vol. 298, pp. 122123. Date of Electronic Publication: 2023 Apr 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prostheses and Implants*
Immunologic Factors*
Humans ; Mice ; Animals ; Genetic Engineering
Czasopismo naukowe
Tytuł:
Management of luspatercept therapy in patients with transfusion-dependent β-thalassaemia.
Autorzy:
Sheth S; Division of Pediatric Hematology/Oncology, Weill Cornell Medicine, New York, New York, USA.
Taher AT; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Coates TD; Cancer and Blood Disease Institute, Children's Hospital Los Angeles and USC Keck School of Medicine, Los Angeles, California, USA.
Kattamis A; First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.
Cappellini MD; Fondazione IRCCS Ca' Granda Policlinico Hospital, University of Milan, Milan, Italy.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2023 Jun; Vol. 201 (5), pp. 824-831. Date of Electronic Publication: 2023 Apr 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
beta-Thalassemia*/drug therapy
beta-Thalassemia*/complications
Immunoglobulin Fc Fragments*/therapeutic use
Immunologic Factors*/therapeutic use
Humans ; Iron Overload/etiology ; Iron Overload/chemically induced ; Quality of Life
Czasopismo naukowe
Tytuł:
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic.
Autorzy:
de Sèze J; Department of Neurology, Hôpital de Hautepierre, Clinical Investigation Center, Institut National de la Santé et de la Recherche Médicale (INSERM), Strasbourg, France.; Fédération de Médecine Translationelle, Institut National de la Santé et de la Recherche Médicale (INSERM), Strasbourg, France.
Maillart E; Department of Neurology, Pitié Salpêtrière Hospital, Paris, France.; Centre de Ressources et de Compétences Sclérose en Plaques, Paris, France.
Gueguen A; Department of Neurology, Rothschild Ophthalmologic Foundation, Paris, France.
Laplaud DA; Department of Neurology, Centre Hospitalier Universitaire (CHU) Nantes, Nantes Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigation Clinique (CIC), Center for Research in Transplantation and Translational Immunology, UMR, UMR1064, Nantes, France.
Michel L; Clinical Neuroscience Centre, CIC_P1414 Institut National de la Santé et de la Recherche Médicale (INSERM), Rennes University Hospital, Rennes University, Rennes, France.; Microenvironment, Cell Differentiation, Immunology and Cancer Unit, Institut National de la Santé et de la Recherche Médicale (INSERM), Rennes I University, French Blood Agency, Rennes, France.; Neurology Department, Rennes University Hospital, Rennes, France.
Thouvenot E; Department of Neurology, Centre Hospitalier Universitaire (CHU) Nîmes, University of Montpellier, Nîmes, France.; Institut de Génomique Fonctionnelle, UMR, Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, Montpellier, France.
Zephir H; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM) U1172, Centre Hospitalier Universitaire (CHU), Lille, France.
Zimmer L; Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Institut National de la Santé et de la Recherche Médicale (INSERM), CNRS, Lyon Neuroscience Research Center, Lyon, France.
Biotti D; Centre Ressources et Compétences Sclérose En Plaques (CRC-SEP) and Department of Neurology, Centre Hospitalier Universitaire (CHU) Toulouse Purpan - Hôpital Pierre-Paul Riquet, Toulouse, France.
Liblau R; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, Institut National de la Santé et de la Recherche Médicale (INSERM), UPS, Toulouse, France.; Department of Immunology, Toulouse University Hospital, Toulouse, France.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Mar 23; Vol. 14, pp. 1004795. Date of Electronic Publication: 2023 Mar 23 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, CD20*/immunology
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/immunology
Immunologic Factors*/pharmacology
Immunologic Factors*/therapeutic use
Humans ; B-Lymphocytes/drug effects ; B-Lymphocytes/immunology ; Recurrence ; Rituximab/therapeutic use ; Rituximab/pharmacology ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies